logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The beauty and skincare sector is showing signs of weakness and volatility, with Lihetech falling to the daily limit.

date
09/06/2026
The beauty and care sector is trending weaker, with LTK falling by the daily limit. Other stocks such as Haoyue care, Pechoy, Jinsheng new materials, Aimei guest, Jinbo biology, and Runben shares also followed the downward trend.
Latest
2 m ago
The A-share energy and metal sector has been fluctuating higher, with Shengxin Lithium Energy rising more than 6%, followed by Yongshan Lithium Industry, Rongjie shares, Yongxing Materials, Ganfeng Lithium Industry, Tianqi Lithium Industry and other individual stocks following the trend.
2 m ago
Hong Kong Stock Moves | Engpu Precision (01286.HK) rose over 4%, completing a net raise of approximately HK$539 million through its old-for-new rights issue, to be used for expanding the AIDC-related terminal market and more.
3 m ago
The Pakistani government: The fiscal year 2027 budget will be submitted in the coming days.
3 m ago
Hong Kong stocks with AI concept are fluctuating and weakening.
4 m ago
GlaxoSmithKline will acquire biopharmaceutical company Nuvalent for $1.06 billion.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.